PediDose exploited advanced Monte Carlo simulations, anthropomorphic computational phantoms, and Artificial Intelligence techniques to develop a simulated dosimetry database.
Benefits:
- Significant strengthening of value proposition for IKHs product Evorad® achieved.
- €1.25m additional total income expected through increased sales of Evorad®.
- Medical market entry for BIOEMTECH facilitated through partnership with IKH.
Read all the details of the success story and watch the video here.
